All
FDA removes screening, monitoring requirement for acne drug
April 1st 2008Washington - The Food and Drug Administration (FDA) has removed a blood-screening and monitoring requirement for Aczone, a topical acne treatment manufactured by QLT USA, a unit of biotech company QLT Inc., Vancouver, British Columbia, the Associated Press reports.
Small prospective trial suggests effectiveness of newly developed frostbite treatment
April 1st 2008St. Paul, Minn. - Using imaging to visualize areas lacking blood flow and deliver clot-breaking, anti-spasmodic drugs via catheter has proved to be an effective treatment for people who suffer severe frostbite, Newswise.com reports.
Johnson & Johnson receives FDA approvable letter for ceftobiprole
April 1st 2008Raritan, N.J. - Johnson & Johnson Pharmaceutical Research & Development has received a Food and Drug Administration (FDA) approvable letter for ceftobiprole, an antibiotic used to treat skin infections, according to an Associated Press report.
Peanut allergy linked to sensitization through skin
April 1st 2008Philadelphia - The mechanism leading to the development of peanut allergy and a potential desensitization treatment for peanut-allergic individuals were among the study findings presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting held here in March, HealthDay News reports.
Ipsen submits BLA to FDA for Reloxin
April 1st 2008Scottsdale, Ariz. - Medicis and Paris-based Ipsen have announced that Ipsen has submitted a Biologics License Application (BLA) to the Food and Drug Administration for the botulinum-toxin product Reloxin to be used in aesthetic indications, news source Prime Newswire reports.
Q & A: Demystifying 529 savings plans
April 1st 2008Yes, a rollover into a different 529 program may be made an unlimited number of times as long as a new beneficiary is named on the account each time. If a rollover is done without changing the beneficiary, no additional rollovers may be completed in the following 12 months unless the beneficiary is changed. In any case, the rollover must be completed within 60 days and you should look into any restrictive terms and charges that may apply.
Unbalanced budget: Medicare reimbursement cut looms in July
April 1st 2008The federal budget for FY 2009, one that provides for $3.1 trillion in federal funding and includes overall Medicare reductions of $196 billion over five years, says about the problem that is the key to continuing Medicare physician reimbursement cuts – the Sustainable Growth Rate (SRG) formula.
Your pharmaceutical rep: How much information can he/she give about off-label use?
April 1st 2008Dr. Doc has an extraordinarily busy dermatology practice. In fact, he is so busy that he has little time to attend medical meetings. He depends on his pharmaceutical representatives to provide him with the latest information about off-label use of various dermatologic prescription drugs. He knows that physician off-label use of prescriptions is not only legal, but is actually encouraged by the Food and Drug Administration (FDA).
Quality reporting: How effective is PQRI?
April 1st 2008The voluntary Physician Quality Reporting Initiative (PQRI), which began in 2007, may be a forerunner of a mandatory pay-for-performance from the Centers for Medicare and Medicaid Services (CMS). Under the PQRI regulations, a physician reports on specific best medical practices he follows. For example, under the PQRI, in 2007, dermatologists who asked patients with a history of melanoma whether they had seen any changes in moles or lesions, did full body exams on those patients and recommended patients do regular skin exams, and then reported they had followed those procedures in 80 percent of their melanoma patients, would earn 1.5 percent of their total CMS reimbursements as a bonus.
Proficiency in reading Mohs pathology sections product of time, volume
April 1st 2008A study tracking the performance of a Mohs surgery fellow in Mohs histopathology section interpretation and mapping found that it took nearly 1,500 Mohs cases which generated 1,350 pathology specimens that were reviewed and immediately graded before the error rate fell to an acceptable level.
Of skin and wit: Derm has passion for medicine, writing and comedy
April 1st 2008At 86, Jerome Z Litt, M.D., is in full-time dermatology practice; is the sole author of the popular Drug Eruption Reference Manual (in its 14th edition, and he has written every one); and has the comedic timing and voice of actor-comedian Mel Brooks.
Protect your investments: Maintain appropriate asset allocation in market downturn and upswing
April 1st 2008With the worst January performance in the history of the stock market behind us, what now? Are we headed for (or already in) a major recession, or is this just another of those predictable bumps in the economic road to financial security?
Stretch marks: Using lasers, light devices for treating striae
April 1st 2008Striae distensae are a very common post-pregnancy complaint in women, yet they frequently occur in other situations as well. Obesity, rapid weight gain or weight loss, puberty or weightlifting can also cause striae. Chronic use of topical steroids, especially in intertriginous or Cushing's syndrome also will lead to stretch marks.
2008-2009 president named for the Women’s Dermatologic Society
March 11th 2008San Francisco - Suzanne M. Connolly, M.D., the new 2008-2009 president of the Women’s Dermatologic Society (WDS), took office in February at the recent WDS luncheon during the American Academy of Dermatology meeting.